Katharina G. McFarland, Director at Transphorm, Inc. (TGAN), sold 3,995 shares at $2.70 ($11K) on 2023-11-22, disclosed to the SEC on 2023-11-27.
Scheduled sale ($11k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TGAN | SELL | 2024-05-24 | $20K | — | Filing → |
| TGAN | SELL | 2024-04-26 | $4K | — | Filing → |
| SAIC | SELL | 2024-04-12 | $191K | — | Filing → |